Published in Cancer Weekly, February 5th, 2002
The study, using human cancer cells in mice, helps explain the puzzling increases in certain chemicals seen in tumor cells and may help increase survival rates from pancreatic cancer, currently one of the world's deadliest.
Dr. Murray Korc, professor of medicine and chief of endocrinology at UCI Medical Center, and his colleagues found that the binding of growth factors to "dummy" receptors - ones incapable of sending signals to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.